# A Comparative Single-Dose Pharmacokinetic (PK) and Safety Study of Azilsartan Medoxomil in Children With Hypertension and in Healthy Adults

> **NCT01078376** · PHASE1 · TERMINATED · sponsor: **Takeda** · enrollment: 29 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Azilsartan medoxomil (TAK-491)
- **DRUG:** Azilsartan medoxomil (TAK-491)
- **DRUG:** Azilsartan medoxomil (TAK-491)
- **DRUG:** Azilsartan medoxomil (TAK-491)

## Key facts

- **NCT ID:** NCT01078376
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-05
- **Primary completion:** 2013-07
- **Final completion:** 2013-09
- **Target enrollment:** 29 (ACTUAL)
- **Why stopped:** Business Decision (see below)
- **Last updated:** 2014-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01078376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01078376, "A Comparative Single-Dose Pharmacokinetic (PK) and Safety Study of Azilsartan Medoxomil in Children With Hypertension and in Healthy Adults". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01078376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*